Home » Trials » SLCTR/2016/011


A double blinded randomized control trial on the effects of standard local infiltration vs laparoscopic guided transverse abdominis plane block for pain relief in laparoscopic cholecystectomy

-

SLCTR Registration Number

SLCTR/2016/011


Date of Registration

22 Apr 2016

The date of last modification

Mar 03, 2019



Application Summary


Scientific Title of Trial

A double blinded randomized control trial on the effects of standard local infiltration vs laparoscopic guided transverse abdominis plane block for pain relief in laparoscopic cholecystectomy


Public Title of Trial

A study comparing two different methods of pain relief following cholecystectomy


Disease or Health Condition(s) Studied

Post cholecystectomy pain relief


Scientific Acronym

None


Public Acronym

None


Brief title

None


Universal Trial Number

None


Any other number(s) assigned to the trial and issuing authority

P/163/10/2015 (Ethics Review Committee, Faculty of Medicine, University of Kelaniya)


Trial Details


What is the research question being addressed?

What is the efficacy of laparoscopic guided transverse abdominis plane block in comparison with conventional port site infiltration for postoperative pain relief following laparoscopic cholecystectomy?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Double blinded


Control

Standard therapy/practice


Assignment

Parallel


Purpose

Treatment


Study Phase

Phase 3


Intervention(s) planned

The study will be carried out in wards 19 and 20 of the North Colombo Teaching Hospital, Ragama, Sri Lanka.

Consenting patients meeting the inclusion/exclusion criteria will be allocated using random number tables into either the intervention or control arm immediately prior to surgery.

The intervention arm will receive unilateral sub costal transverse abdominis plane block with 40ml of 0.25% plain bupivacaine + local infiltration of 0.5% plain bupivacaine 5-10ml at each port sites. (The port sites will be epigastric, right iliac fossa, right hypochondrium and umbilical.)

The control arm will receive only local infiltration of 0.5% plain bupivacaine 5-10ml at each port sites. (The port sites will be epigastric, right iliac fossa, right hypochondrium and umbilical.)

The interventions will be carried out by an investigator and the patients then handed over to the surgeon who will be blind to the intervention status of the patient. All interventions will take place once the patient is under general anaesthesia, and thus blind to their intervention status.

Outcomes will be assessed by an independent investigator who will also be blinded to the intervention status.


Inclusion criteria

All patients undergoing elective laparoscopic cholecystectomy


Exclusion criteria

  1. Patients who undergo emergency laparoscopic cholecystectomy
  2. Conversion from laparoscopy to open cholecystectomy
  3. Patients with blood coagulation pathologies
  4. Known allergy to local anesthetic drugs
  5. Duration of surgery more than two hours
  6. Patients with intra operative or perioperative complications
  7. Pregnant women
  8. Body weight less than 30kg


Primary outcome(s)

1.

Need for post-operative rescue analgesia with sub cutaneous morphine

[

At 36 hours post operatively

]

Secondary outcome(s)

1.

Post operative pain (assessed by visual analog score)

[

At 6,12,18,24 & 36 hours after the surgery.

]
2.

Duration of immobilization

[

Time taken to walk to the washroom after the surgery.

]
3.

Occurrence of post operative vomiting

[

6 hourly up to 36 hours after the surgery

]
4.

Duration of hospital stay

[

At time of discharge

]

Target number/sample size

90 (45 in each arm)


Countries of recruitment

Sri Lanka


Anticipated start date

2016-05-01


Anticipated end date

2016-11-01


Date of first enrollment

2016-04-24


Date of study completion


Recruitment status

Recruiting


Funding source

None (Investigator funded)


Regulatory approvals

Not applicable



State of Ethics Review Approval


Status

Approved


Date of Approval

2015-10-14


Approval number

P/163/10/2015


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medicine, University of Kelaniya
Institutional Address:PO Box 6, Thalagolla Road, Ragama Sri Lanka
Telephone:+94-11-2961267
Email: erckelaniya@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr. Rohan Chaminda Siriwardana
Consultant hepatobiliary surgeon
Department of Surgery, Faculty of Medicine, Ragama
Tel: 0775544015
Mob: 0777250213

rohansiriwardana@yahoo.com

Contact Person for Public Queries

Dr. Rohan Chaminda Siriwardana
Consultant hepatobiliary surgeon
Department of Surgery, Faculty of Medicine, Ragama
Tel: 0775544015
Mob: 0777250213

rohansiriwardana@yahoo.com


Primary study sponsor/organization

Department of Surgery, Faculty of Medicine, University of Kelaniya

Thalagolla Rd, Ragama, Sri Lanka
Tel: +94112961000
Fax: +94112958337

Web: http://www.kln.ac.lk/medicine/depts/surgery/

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description

Not Available


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results